TW341575B - Progestationally active 19,11-bridged 4-estrenes - Google Patents

Progestationally active 19,11-bridged 4-estrenes

Info

Publication number
TW341575B
TW341575B TW082109012A TW82109012A TW341575B TW 341575 B TW341575 B TW 341575B TW 082109012 A TW082109012 A TW 082109012A TW 82109012 A TW82109012 A TW 82109012A TW 341575 B TW341575 B TW 341575B
Authority
TW
Taiwan
Prior art keywords
hydrogen atom
additional bond
together form
bridged
estrenes
Prior art date
Application number
TW082109012A
Other languages
English (en)
Inventor
Eckhard Ottow Dr
Wolfgang Schwede Dr
Wolfgang Halfbrodt Dr
Larl-Heinrich Fritzemeier Dr
Rolrf Krattenmacher Dr
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of TW341575B publication Critical patent/TW341575B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
TW082109012A 1992-10-13 1993-10-28 Progestationally active 19,11-bridged 4-estrenes TW341575B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4235220A DE4235220A1 (de) 1992-10-13 1992-10-13 Gestagen wirksame 19,11ß-überbrückte 4-Estrene

Publications (1)

Publication Number Publication Date
TW341575B true TW341575B (en) 1998-10-01

Family

ID=6470806

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082109012A TW341575B (en) 1992-10-13 1993-10-28 Progestationally active 19,11-bridged 4-estrenes

Country Status (25)

Country Link
US (2) US5523298A (zh)
EP (1) EP0664811B1 (zh)
JP (1) JP3302366B2 (zh)
KR (1) KR100341066B1 (zh)
CN (1) CN1052238C (zh)
AT (1) ATE156837T1 (zh)
AU (1) AU677019B2 (zh)
BR (1) BR9307232A (zh)
CA (1) CA2146962A1 (zh)
CZ (1) CZ284187B6 (zh)
DE (2) DE4235220A1 (zh)
DK (1) DK0664811T3 (zh)
ES (1) ES2108298T3 (zh)
FI (1) FI951760A (zh)
GR (1) GR3024940T3 (zh)
HU (1) HU223315B1 (zh)
IL (1) IL107232A (zh)
NO (1) NO305440B1 (zh)
NZ (1) NZ256865A (zh)
PL (1) PL179764B1 (zh)
RU (1) RU2157814C2 (zh)
SK (1) SK280991B6 (zh)
TW (1) TW341575B (zh)
WO (1) WO1994009025A1 (zh)
ZA (1) ZA937614B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4235220A1 (de) * 1992-10-13 1994-06-16 Schering Ag Gestagen wirksame 19,11ß-überbrückte 4-Estrene
DE4413185A1 (de) * 1994-04-12 1995-10-19 Schering Ag 11beta,19-überbrückte 13alpha-Alkylsteroide
DE4413184A1 (de) * 1994-04-12 1995-10-19 Schering Ag 10,11-C¶3¶-überbrückte Steroide
US5912006A (en) * 1996-08-28 1999-06-15 Eboc, Inc. Compositions and methods for alleviating discomforting menstrual pain
JP2004516841A (ja) * 2000-12-28 2004-06-10 シエーリング アクチエンゲゼルシャフト プロゲステロンレセプターアイソフォーム特異的リガンドおよび組織選択的プロゲステロンレセプターリガンドについてスクリーニングする方法
US20040121304A1 (en) * 2001-12-21 2004-06-24 Ulrike Fuhrmann Method for screening for progesterone receptor isoform-specific ligands and for tissue-selective progesterone receptor ligands
GB0219345D0 (en) * 2002-08-20 2002-09-25 Givaudan Sa Improvements in or relating to organic compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3465010A (en) * 1966-11-22 1969-09-02 Searle & Co 17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof
DE3708942A1 (de) * 1987-03-18 1988-09-29 Schering Ag 19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
US5446178A (en) * 1987-03-18 1995-08-29 Schering Aktiengesellschaft Process for preparing 19,11β-bridged steroids
DE3717169A1 (de) * 1987-05-19 1988-12-01 Schering Ag 19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3832303A1 (de) * 1988-09-20 1990-04-12 Schering Ag 11ss-phenyl-14ssh-steroide
DE3917274A1 (de) * 1989-05-24 1990-11-29 Schering Ag 9(alpha)-hydroxy-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE4038128A1 (de) * 1990-11-27 1992-06-04 Schering Ag 8-en-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE4235220A1 (de) * 1992-10-13 1994-06-16 Schering Ag Gestagen wirksame 19,11ß-überbrückte 4-Estrene

Also Published As

Publication number Publication date
BR9307232A (pt) 1999-08-24
ATE156837T1 (de) 1997-08-15
NZ256865A (en) 1996-04-26
EP0664811A1 (de) 1995-08-02
DK0664811T3 (da) 1998-03-30
DE59307133D1 (de) 1997-09-18
FI951760A0 (fi) 1995-04-12
JPH08502276A (ja) 1996-03-12
WO1994009025A1 (de) 1994-04-28
HUT71523A (en) 1995-12-28
KR950703576A (ko) 1995-09-20
IL107232A0 (en) 1994-01-25
DE4235220A1 (de) 1994-06-16
KR100341066B1 (ko) 2002-12-06
AU677019B2 (en) 1997-04-10
US5703066A (en) 1997-12-30
IL107232A (en) 1998-06-15
NO951444D0 (no) 1995-04-12
HU9501057D0 (en) 1995-06-28
CN1052238C (zh) 2000-05-10
AU5177493A (en) 1994-05-09
ZA937614B (en) 1994-05-23
NO305440B1 (no) 1999-05-31
HU223315B1 (hu) 2004-05-28
US5523298A (en) 1996-06-04
GR3024940T3 (en) 1998-01-30
FI951760A (fi) 1995-04-12
PL308349A1 (en) 1995-07-24
CN1092428A (zh) 1994-09-21
NO951444L (no) 1995-06-13
SK280991B6 (sk) 2000-10-09
ES2108298T3 (es) 1997-12-16
CA2146962A1 (en) 1994-04-28
JP3302366B2 (ja) 2002-07-15
RU2157814C2 (ru) 2000-10-20
CZ284187B6 (cs) 1998-09-16
EP0664811B1 (de) 1997-08-13
SK49495A3 (en) 1995-08-09
CZ91995A3 (en) 1995-09-13
PL179764B1 (pl) 2000-10-31
RU95109891A (ru) 1997-02-10

Similar Documents

Publication Publication Date Title
DK0393457T3 (da) Proteinaseinhibitor
ATE236889T1 (de) N-halogenierte säureamide
ATE100123T1 (de) Stabilisieren von unter abspaltung von alkoholen zu elastomeren vernetzaren organopolysiloxanmassen.
TW341575B (en) Progestationally active 19,11-bridged 4-estrenes
CA2193460A1 (en) 3-amino-2-mercaptobenzoic acid derivatives and processes for their preparation
AU532749B2 (en) 6-arylpyridazin-3-ones
CA2116617A1 (en) Novel esculetin derivatives and pharmaceutical composition
MX9303990A (es) Tetrazolil (fenoxi y fenoxialquil) piperidinil piridazinas como agentes antivirales.
DE69318525T2 (de) Lithiumsalze enthaltende flexible Polyurethanschaumstoffe, ihr Herstellungsverfahren und Polyolzusammensetzung dafür
ATE73660T1 (de) 9-halogenprostaglandin-clathrate und ihre verwendung als arzneimittel.
AU558271B2 (en) 5-(4-vinyl-or-4-ethynylbenzoyl)-1,2-dihydro-3h-pyrrolo- (1,2-a)-pyrrole-1-carboxylic acids
MX9709963A (es) Sucralosa solida.
ES454283A1 (es) Procedimiento para la produccion de un peptido.
DE3560110D1 (en) Derivatives of 2-alkoxyaminosulfonylbenzenesulfonylurea
AU571986B2 (en) 17,21-diacylates of 9-alpha-fluoro or chloro 17,21 -dihydroxy-corticosteroids
ES468107A1 (es) Procedimiento para la preparacion de derivados de la 9-fluo-roprednisolona
ES467744A1 (es) Un procedimiento para preparar un fungicida que contiene sa-les organicas de amonio cuaternario
VANDERSCHAFT On the Hamilton-Jacobi equation of nonlinear H sub infinity optimal control
PH18551A (en) Fluorophenoxybenzyl esters and the composition containing same
GR850567B (zh)
FR2689523B1 (fr) Cellule bipolaire pour l'electrolyse en continu du chlorure de sodium.
RU1775517C (ru) Устройство дл контрол перекоса утка в ткан х
CA2096307A1 (en) Tertiary Amides Useful as Low-Foam Wetting Agents in the Textile Industry
DE69620121T2 (de) Gefüllte thermoplastische Polyolefinzusammensetzung
IT9011709V0 (it) Quadro modulare per l'alimentazione di impianti ferroviari